Can-Fite BioPharma Ltd Forecast and Stock Analysis
Technical CANF stock analysis for Wednesday May 22, 2019.
|Shorts||0.93% ( 2019-04-15 )|
|Price to book||USD 1.97|
|Next Earnings Date||2019-05-31|
Can-Fite BioPharma Ltd fell by -7.47% in the last day ( Wednesday, 22nd May 2019 ) from $3.48 to $3.22 During day the stock fluctuated 12.01% from a day low at $3.08 to a day high of $3.45. The price has fallen in 6 of the last 10 days , but is still up by 722.27% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1 967 618 shares and in total 478 474 shares bought and sold for approximately $1.54 million.
- 30 day high of the CANF stock price was $8.88 and low was $0.38.
- 90 day high was $8.88 and low was $0.38.
- 52 week high for the Can-Fite BioPharma Ltd - $8.88 and low - $0.38.
Can-Fite BioPharma Ltd lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.91% during the next 3 months and, with 90% probability hold a price between $1.16 and $10.25 at the end of this period.
Can-Fite BioPharma Ltd holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $4.65. On a fall, the stock will find some support from the long-term average at approximately $1.68. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Friday May 10, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 64 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.37 between high and low, or 12.01%. For the last week, the stock has had a daily average volatility of 51.46%.
Our recommended stoploss: $3.04 (-5.72%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 8 days ago.)
51.46 %Average volatility
Very Low Low Medium High Very High
Can-Fite BioPharma Ltd holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us